Direktorat Registrasi ObatValid

THEOPHYLLINE

BPOM Number: GKL2605069906A1
Approved: 27 June 2026
Expiry: 12 April 2031
Form: KAPLET PELEPASAN LAMBAT

About This Registration

THEOPHYLLINE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL2605069906A1. Its current registration status is Valid, with the licence valid until 12 April 2031. The product is registered to DEXA MEDICA - INDONESIA. BPOM first approved this registration in April 2026. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 5 July 2026. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application: newaero
Packaging: DUS, 10 STRIP @ 10 KAPLET PELEPASAN LAMBAT
Department: Direktorat Registrasi Obat
Data Last Updated: 5 July 2026

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

DEXA MEDICA - INDONESIA
KOTA PALEMBANG
NPWP: 12345678910
owner
View profile →

Manufacturing Sites

DEXA MEDICA - INDONESIA
KOTA PALEMBANG
primary
View profile →

Ingredients (1)

THEOPHYLLINE

Market Intelligence

Owner Portfolio: DEXA MEDICA - INDONESIA holds 535 BPOM registrations
Manufacturer Scale: DEXA MEDICA - INDONESIA produces 535 registered products
Registration Age: Registered for 5 months
Update Status: Recently updated (88 days ago)

FDA Cross-Reference

via openFDA

Generic Name: THEOPHYLLINE ANHYDROUS
Product Type: HUMAN PRESCRIPTION DRUG
Route of Administration: ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?